ANZACT ENDORSEMENT
Members are invited to apply for ANZACT Endorsement
The purpose of Endorsement is to provide an easily recognised symbol of relevant and high-quality research that can be applied to grant applications or funded projects. Endorsement will provide a strategic mechanism to support members with a culture of collaboration, increased recruitment to clinical trials, and a path for dissemination of their research results.
ANZACT is a facilitating Clinical Trials Network, with a key role as a point of contact for organisations seeking to engage in projects with our members. Whilst our focus is on capacity-building activities for investigator-initiated clinical trials, we welcome enquiries from biomedical and pharmaceutical industries and other organisations.
Process for ANZACT Endorsement
Eligibility
- Only members are eligible to apply for ANZACT Endorsement – and it’s free to join
Application
- Members complete an Application Form for Endorsement on the ANZACT website
- The Chair of the Scientific Committee will appoint a minimum of 2 members and 1 consumer to review the application and recommend either Further Development or Endorsement.
The criteria for selection will include:
- Significance of the research question, including burden of disease (on the individual or health system), gaps in evidence, and alignment with national priorities
- Research quality, including innovation and ‘implementability’ (the ability to be translated into practice or policy)
- Evidence of consumer input
- Evidence of (i) collaboration, and (ii) potential for multiple sites will be well regarded
- Recommendations are reviewed by the Chair of the Scientific Committee and proposed to the Executive Team for approval
- Endorsed proposals are required to comply with the Conditions of Endorsement
Conditions of Endorsement
- A liaison person is nominated as a primary point of contact
- Evidence of HREC approval is provided to ANZACT in a timely manner
- Trials are registered on an appropriate registry (eg, ANZCTR) before recruitment commences
- The liaison person will provide Progress and Annual reports using either a copy of the HREC Report or a template that includes:
- Brief description of activities to date, and challenges encountered
- Target and number of sites open to recruitment
- Target and number of patients recruited
- All publications, presentations, etc. will include an acknowledgment of ‘Endorsed by ANZACT’
- The project is presented at a mutually-agreed ANZACT event
- The Executive Officer is notified of acceptance of manuscripts and expected publication dates